We are live on ! Find out more
SCP

Seizert Capital Partners Portfolio holdings

AUM $2.42B
1-Year Est. Return 22.12%
This Fund
S&P 500
This Quarter Est. Return
+2.39%
1 Year Est. Return
+22.12%
3 Year Est. Return
+73.42%
5 Year Est. Return
+88.59%
10 Year Est. Return
+355.73%
AUM
$4.27B
AUM Growth
+$48.5M
Cap. Flow
-$56.2M
Cap. Flow %
-1.31%
Top 10 Hldgs %
25.34%
Holding
228
New
16
Increased
73
Reduced
85
Closed
20

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$94.1M
2
ESV
Ensco Rowan plc
ESV
+$85.7M
3
AGO icon
Assured Guaranty
AGO
+$71.1M
4
AGCO icon
AGCO
AGCO
+$28.4M
5
URS
URS CORP
URS
+$25.5M

Sector Composition

Rank Sector Weight
1 Financials 24.7%
2 Technology 21.56%
3 Healthcare 13.37%
4 Energy 10.33%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
76
HP
HPQ
$26.1B
$8.73M 0.2%
594,307
+165,996
+39% +$2.23M
PRU icon
77
Prudential Financial
PRU
$41.5B
$8.22M 0.19%
97,079
-4,080
-4% -$351K
NSC icon
78
Norfolk Southern
NSC
$76.8B
$7.05M 0.16%
72,520
-3,175
-4% -$294K
TEVA icon
79
Teva Pharmaceuticals
TEVA
$40.5B
$5.11M 0.12%
+96,728
New +$4.47M
NOV icon
80
NOV
NOV
$6.95B
$2.97M 0.07%
+42,289
New +$2.9M
WFC icon
81
Wells Fargo
WFC
$270B
$2.94M 0.07%
59,028
+1,598
+3% +$74.4K
KLIC icon
82
Kulicke & Soffa
KLIC
$4.91B
$2.41M 0.06%
190,999
+22,407
+13% +$266K
EPD icon
83
Enterprise Products Partners
EPD
$81.6B
$2.37M 0.06%
68,216
IMOS
84
ChipMOS TECHNOLOGIES
IMOS
$1.77B
$2.3M 0.05%
94,480
-9,832
-9% -$225K
BMY icon
85
Bristol-Myers Squibb
BMY
$130B
$2.21M 0.05%
42,531
-357
-0.8% -$19K
MBTF
86
DELISTED
MBT Financial Corporation
MBTF
$2.13M 0.05%
433,201
-40,000
-8% -$201K
SGY
87
DELISTED
Stone Energy
SGY
$2.11M 0.05%
884
+73
+9% +$143K
ITG
88
DELISTED
Investment Technology Group Inc
ITG
$2.11M 0.05%
104,275
+26,530
+34% +$479K
NSU
89
DELISTED
Nevsun Resources Ltd.
NSU
$2.08M 0.05%
617,271
+49,856
+9% +$186K
FCRE
90
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$1.97M 0.05%
24,926
+5,670
+29% +$413K
BPOP icon
91
Popular Inc
BPOP
$11.3B
$1.97M 0.05%
63,405
+5,185
+9% +$148K
QLGC
92
DELISTED
QLOGIC CORP
QLGC
$1.94M 0.05%
+152,255
New +$1.78M
COP icon
93
ConocoPhillips
COP
$140B
$1.89M 0.04%
26,823
-3,774
-12% -$253K
EGY icon
94
Vaalco Energy
EGY
$551M
$1.84M 0.04%
+215,630
New +$1.45M
PDLI
95
DELISTED
PDL BioPharma, Inc.
PDLI
$1.81M 0.04%
217,820
+51,370
+31% +$440K
ZD icon
96
Ziff Davis
ZD
$1.94B
$1.78M 0.04%
40,958
-6,261
-13% -$264K
QUAD icon
97
Quad
QUAD
$529M
$1.77M 0.04%
+75,355
New +$1.8M
KG
98
Kestrel Group
KG
$68.9M
$1.75M 0.04%
7,004
+2,984
+74% +$689K
PLAB icon
99
Photronics
PLAB
$1.89B
$1.72M 0.04%
201,805
+15,750
+8% +$133K
BH icon
100
Biglari Holdings Class B
BH
$1.25B
$1.72M 0.04%
5,690
+1,643
+41% +$473K

Similar funds

Seizert Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Seizert Capital Partners held 228 positions worth $4.27B, up 1.1% from $4.23B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Seizert Capital Partners's Q1 2014 filing shows 16 new, 73 increased, 85 reduced and 20 closed positions. Its largest new stake was Ensco Rowan plc: 409,703 shares worth $86.5M. The largest sale was United Therapeutics, an estimated $73.8M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.

  • Seizert Capital Partners's largest Q1 2014 buy was Ensco Rowan plc: 409,703 shares worth $86.5M.
  • Seizert Capital Partners added most to Gen Digital in Q1 2014, an estimated $94.1M increase.
  • Seizert Capital Partners's biggest Q1 2014 reduction was Endo International plc, cutting an estimated $52.9M.
  • Seizert Capital Partners fully exited United Therapeutics in Q1 2014, selling an estimated $73.8M.
  • Seizert Capital Partners's ten largest holdings make up 25% of its $4.27B portfolio in Q1 2014.
  • Seizert Capital Partners opened 16 new positions and closed 20 in Q1 2014.
  • Seizert Capital Partners's portfolio value rose 1.1% quarter-over-quarter to $4.27B.

Based on Seizert Capital Partners's 13F filing for Q1 2014, filed 8 May 2014.